Treatment of unresectable carcinoma of the esophagus or the gastroesophageal junction by mesh stents with or without radiochemotherapy.

Endoscopic palliative treatment for esophageal and gastric cancer: techniques, complications, and survival in a population-based cohort of 948 patients

“…Perhaps surprisingly, no immediate deaths were recorded here. The incidence of stent migration, bolus obstruction, pain, and bleeding is compatible with smaller series [10,25], but we found no evidence that radiotherapy or chemotherapy after stent placement increased the risk of stent migration or the need for stent replacement [17]. Although failure to record such events during prospective data collection remains a potential source of error, the data-cleaning exercise (which included retrieval and cross-checking of 10% of the case notes) did not provide evidence of such omissions.…”

Development of severe complications caused by stent placement followed by definitive radiation therapy for T4 esophageal cancer

“…2 Some reports indicate that patients with unresectable esophageal cancer (ranging from T2N1M0 to T4N2M1) who received concurrent radiation and chemotherapy before being treated with a mesh stent experienced prolonged survival compared with patients of equal tumor staging who were not treated with the stents. 16 There are many reports regarding esophageal stenting for malignant esophageal stenosis. They indicate that esophageal stenting provides excellent palliation with few severe complications in the short-term.…”

Delayed Complications after Placement of Self-Expanding Stents in Malignant Esophageal Obstruction: Treatment Strategies and Survival Rate

“…However, favorable factors such as ease of placement, rapid relief of dysphagia, and improvement of quality of life should be weighed against delayed complications, including tumor in-or overgrowth, food bolus obstruction, development of fistulas, and stent migration [3][4][5][6][7]. Recurrent dysphagia being the leading symptom of stent dysfunction has been observed in this study and by others in as many as 50% of patients during a follow-up of 4-10 weeks [10,11]. Recanalization procedures such as laser therapy or further stent insertion, but also systemic chemotherapy and radiation seem to be of major importance to prolong stent patency [4,[6][7][8][9][10][11][12][13][14].…”